Home
>
National Drug Code (NDC)
>
Glipizide
Glipizide - 0615-3595-05 - (Glipizide)
Drug Information of Glipizide
| Product NDC: | 0615-3595 |
| Proprietary Name: | Glipizide |
| Non Proprietary Name: | Glipizide |
| Active Ingredient(s): | 5 mg/1 & nbsp; Glipizide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Glipizide
| Product NDC: | 0615-3595 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074226 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19940510 |
Package Information of Glipizide
| Package NDC: | 0615-3595-05 |
| Package Description: | 15 TABLET in 1 BLISTER PACK (0615-3595-05) |
NDC Information of Glipizide
| NDC Code | 0615-3595-05 |
| Proprietary Name | Glipizide |
| Package Description | 15 TABLET in 1 BLISTER PACK (0615-3595-05) |
| Product NDC | 0615-3595 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Glipizide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19940510 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | GLIPIZIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |
